James Neal

Insider Reports History

Entity
Individual
Location
2910 Seventh Street, Berkeley, CA
Signature
/s/ James Neal by Neda Sharifi, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Neal:

Stock Role Class Num Shares Value Price $ Report Date Ownership
XOMA Corp CEO, Director Depositary Shares - 8.375% B Cumulative Stock 8K $190K $23.79 Jul 15, 2022 By spouse
XOMA Corp CEO, Director Common Stock 11.8K $164K $13.89 Jul 15, 2022 Direct
XOMA Corp CEO, Director Common Stock 5.56K $77.2K $13.89 Jul 15, 2022 By 401(k) Plan
PALISADE BIO, INC. Director Common Stock, par value $0.01 10.9K $4.76K $0.44 Feb 9, 2024 Direct
PALISADE BIO, INC. Director Restricted Stock Units 0 $0 $0.44 Feb 9, 2024 Direct
XOMA Corp CEO, Director Stock Option (Right to Buy) 218K Jul 15, 2022 Direct
Monterey Bio Acquisition Corp Director Common Stock 35K Sep 30, 2021 Direct
Peak Bio, Inc. Director Warrant (Right to Purchase) 33.3K Apr 28, 2023 Direct
Processa Pharmaceuticals, Inc. Director Restricted Stock 31.2K Sep 3, 2024 Direct
XOMA Corp CEO, Director 8.625% Series A Cumulative Perpetual Preferred Stock 8K Jul 15, 2022 By spouse
PALISADE BIO, INC. Director Common Stock Options 6.88K Feb 9, 2024 Direct
Peak Bio, Inc. Director Convertible Notes $20K Apr 28, 2023 Direct

Insider Reports Filed by James Neal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCSA Processa Pharmaceuticals, Inc. Sep 3, 2024 1 $0 4 Sep 18, 2024 Director
PALI PALISADE BIO, INC. Feb 9, 2024 8 $0 4 Feb 13, 2024 Director
PALI PALISADE BIO, INC. Nov 21, 2023 2 $0 4 Nov 24, 2023 Director
PCSA Processa Pharmaceuticals, Inc. Jun 27, 2023 3 $0 4 Jul 24, 2023 Director
PALI PALISADE BIO, INC. Jun 11, 2023 2 $0 4 Jun 13, 2023 Director
PKBO Peak Bio, Inc. Apr 28, 2023 2 $20K 4 May 2, 2023 Director
PKBO Peak Bio, Inc. Nov 1, 2022 0 $0 3 Nov 3, 2022 Director
PCSA Processa Pharmaceuticals, Inc. Jul 19, 2022 1 $0 4 Jul 21, 2022 Director
PCSA Processa Pharmaceuticals, Inc. Jul 19, 2022 0 $0 3 Jul 21, 2022 Director
XOMA XOMA Corp Jul 15, 2022 5 -$645K 4 Jul 18, 2022 CEO, Director
XOMA XOMA Corp Mar 21, 2022 9 -$1.34M 4 Mar 23, 2022 CEO, Director
XOMA XOMA Corp Dec 21, 2021 1 $0 4 Dec 23, 2021 CEO, Director
PALI PALISADE BIO, INC. Nov 18, 2021 1 $0 4 Feb 10, 2022 Director
MTRY Monterey Bio Acquisition Corp Sep 30, 2021 0 $0 3 Sep 30, 2021 Director
XOMA XOMA Corp Jun 25, 2021 3 -$303K 4 Jun 29, 2021 CEO, Director